Navana Pharmaceuticals PLC (DSE: NAVANAPHAR)
Health Care · Pharmaceuticals · BD
Tk61.30
-3.46% today · +17.0% 1Y
Navana Pharmaceuticals PLC (DSE: NAVANAPHAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $53.46M.
Over the last twelve months the share price has gained 17.0%, trading between 45.50 and 78.00.
Tweenvest scores Navana Pharmaceuticals PLC across four factors: quality 70/100, value 65/100, growth 80/100, dividend 56/100. Its strongest factor is growth.
NAVANAPHAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $53.46M
- Revenue (TTM)
- $86.17M
- P/E
- 10.94
- EPS
- 5.60
- Dividend yield
- 2.28%
- Beta (5Y)
- 0.19
- 52-week high
- Tk78.00
- 52-week low
- Tk45.50
- Avg volume (3M)
- —
- Shares outstanding
- 107.42M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chi Sheng Pharma & Biotech Co., LtdTPEX: 4111 | $54.27M | NT$29.00 | +1.05% |
| LeonaBio, Inc.NasdaqCM: LONA | $54.17M | $6.14 | +6.78% |
| CTCBIO Inc.KOSDAQ: A060590 | $54.06M | ₩3,040.00 | -1.62% |
| Wai Yuen Tong Medicine Holdings LimitedSEHK: 897 | $53.96M | HK$0.38 | +1.33% |
| Citi Pharma LimitedKASE: CPHL | $53.43M | PKRs64.76 | -9.88% |
| Moberg Pharma AB (publ)OM: MOB | $53.32M | Skr11.50 | +1.77% |
| Odonate, Inc.OTCPK: ODTC | $53.25M | $— | — |
| Modern Chinese Medicine Group Co., Ltd.SEHK: 1643 | $53.21M | HK$0.58 | -12.78% |
Figures last refreshed Oct 11, 2026.